Fred Alger Management’s Amicus Therapeutics FOLD Stock Holding History

Fred Alger Management’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-70,000	Closed	-$952K	–	530
2019 Q1	$952K	Buy	70,000 +20,000	+40%	+$244K	﹤0.01%	339
2018 Q4	$479K	Sell	50,000 -58,000	-54%	-$638K	﹤0.01%	355
2018 Q3	$1.31M	Buy	108,000 +3,000	+3%	+$42K	﹤0.01%	308
2018 Q2	$1.64M	Hold	105,000	–	–	0.01%	291
2018 Q1	$1.58M	Sell	105,000 -3,000	-3%	-$45.7K	0.01%	310
2017 Q4	$1.55M	Sell	108,000 -2,000	-2%	-$27.5K	0.01%	304
2017 Q3	$1.66M	Buy	110,000 +40,000	+57%	+$529K	0.01%	296
2017 Q2	$705K	Hold	70,000	–	–	﹤0.01%	352
2017 Q1	$499K	Buy	70,000 +10,000	+17%	+$63.2K	﹤0.01%	362
2016 Q4	$298K	Sell	60,000 -50,150	-46%	-$347K	﹤0.01%	343
2016 Q3	$815K	Hold	110,150	–	–	﹤0.01%	321
2016 Q2	$601K	Buy	110,150 +5,000	+5%	+$35K	﹤0.01%	365
2016 Q1	$889K	Sell	105,150 -14,500	-12%	-$103K	﹤0.01%	385
2015 Q4	$1.16M	Sell	119,650 -243,284	-67%	-$2.19M	0.01%	374
2015 Q3	$5.08M	Sell	362,934 -69,252	-16%	-$1.09M	0.03%	268
2015 Q2	$6.12M	Buy	432,186 +30,118	+7%	+$362K	0.03%	278
2015 Q1	$4.37M	Buy	+402,068	New	+$3.54M	0.02%	356

Other funds holding FOLD

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Fred Alger Management's FOLD Position: Q2 2019 in Review

Fred Alger Management sold out of Amicus Therapeutics (FOLD) in Q2 2019, closing a stake of 70,000 shares — an estimated $952K sold.

Fred Alger Management first reported a position in FOLD in Q1 2015 and held it in 17 quarters. The position peaked at $6.12M in Q2 2015. 206 funds tracked by Wall St. Rank hold FOLD as of Q2 2019.

Fred Alger Management reported no remaining Amicus Therapeutics position as of Q2 2019 after selling out during the quarter.
Fred Alger Management sold 70,000 Amicus Therapeutics shares in Q2 2019, an estimated $952K.
Fred Alger Management first reported a position in Amicus Therapeutics in Q1 2015 and held it in 17 quarters.
Fred Alger Management's Amicus Therapeutics position peaked at $6.12M in Q2 2015.
206 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2019.

Based on Fred Alger Management's 13F filing for Q2 2019, filed 14 Aug 2019.